Resilience
PrivateLast Round
Debt
Oct 29, 2025
Total Funding Raised
$2.45B
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Resilience is a biopharmaceutical manufacturing company that provides end-to-end manufacturing solutions for biologics, vaccines, and cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resilience Comparables
Compare Resilience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ElevateBio | 82% | |
| WuXi Biologics | 82% | |
| Lonza Group | 80% |
For institutional investors. Book with your work email.
Resilience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 29, 2025 | ||||
| VC Round | Jun 9, 2025 | ||||
| Grant | Oct 3, 2024 | ||||
| Debt | Mar 28, 2023 | ||||
| Private Equity | Jan 10, 2023 | ||||
Series D | Jun 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Resilience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Administration for Strategic Preparedness and Response | Grant |
| GV | Series B |
| New Enterprise Associates | Series B |
| ARCH Venture Partners | Series A, Series B |
| U.S. Department of War | Debt |
| 8VC | Series A, Series B |
| Oak Hill Advisors | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 43% MoM, reaching 25.2K.
- Apr 4, 2026
New commercial site in Blue Ash, Ohio, for IDAP operations.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- sells_assets_toSep 21, 2026
Resilience sells Made Scientific an 85,000 sq. ft. clinical- to commercial-scale cell therapy manufacturing facility in East Norriton, Pennsylvania, with the transaction closing on Sep 18th '26.
- increases_headcount_bySep 14, 2026
Resilience is expected to create 400 high-skilled jobs at its Cincinnati-region manufacturing facility in Ohio as part of its KwikPen expansion announced in Jul '26, with full operations anticipated by early 2027.
- partners_withSep 14, 2026
On Sep 15th '26, Resilience partners with Ohio Life Sciences to promote a strong pipeline of high-skilled manufacturing talent in Ohio.
- increases_headcount_byAug 10, 2026
Resilience plans to add about 200 jobs in Ohio as it moves its global headquarters from San Diego, with the project announced in Jun '26.
For institutional investors. Book with your work email.
Resilience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Resilience's valuation, stock price, and market status.
Is Resilience a public or private company?
Resilience is a private company.
What is the current stock price of Resilience?
Resilience is a private company, so its shares have no public market price. Caplight tracks Resilience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Resilience worth (valuation)?
Valuation information for Resilience is not publicly available.
Can I buy Resilience stock?
Resilience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Resilience's last funding round?
Resilience's most recent funding round was Debt on October 29, 2025.
Who are the main investors in Resilience?
Key investors in Resilience include ARCH Venture Partners, 8VC, Oak Hill Advisors, Mubadala Investment Company.
Will Resilience IPO soon?
No public IPO plans have been announced for Resilience.
How can I track Resilience secondary market activity?
Caplight tracks bids, offers, and trades in Resilience's shares on secondary markets.